Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dense Breasts”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Not applicableStudy completedNCT02977247
What this trial is testing

Delphinus SoftVue Prospective Case Collection - ARM 2

Who this might be right for
Breast Neoplasms
Delphinus Medical Technologies, Inc. 1,150
Not applicableStudy completedNCT00816530
What this trial is testing

A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.

Who this might be right for
Breast Cancer
U-Systems, Inc. 15,679
Testing effectiveness (Phase 2)Study completedNCT00394251
What this trial is testing

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene 197
Large-scale testing (Phase 3)Study completedNCT00431080
What this trial is testing

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 478
Testing effectiveness (Phase 2)Study completedNCT00944047
What this trial is testing

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Who this might be right for
Breast Cancer
University of Kansas Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT02489448
What this trial is testing

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Yale University 68
Testing effectiveness (Phase 2)Looking for participantsNCT05728268
What this trial is testing

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Who this might be right for
Breast Cancer
Shantou Central Hospital 64
Not applicableStudy completedNCT03972605
What this trial is testing

Delphinus SoftVue™ ROC Reader Study

Who this might be right for
Breast Cancer DetectionDense Breast ParenchymaBenign Breast Findings+2 more
Delphinus Medical Technologies, Inc. 32
Large-scale testing (Phase 3)Study completedNCT01690702
What this trial is testing

Study of Nab-Paclitaxel in High Risk Early Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 2,886
Testing effectiveness (Phase 2)Active Not RecruitingNCT04418154
What this trial is testing

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Fudan University 70
Not applicableStudy completedNCT04688086
What this trial is testing

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Who this might be right for
Breast CancerEarly Detection of Cancer
Niramai Health Analytix Private Limited 687
Testing effectiveness (Phase 2)Study completedNCT00193206
What this trial is testing

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 123
Testing effectiveness (Phase 2)Study completedNCT00209092
What this trial is testing

Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Emory University 51
Not applicableStudy completedNCT00343863
What this trial is testing

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Who this might be right for
Male Breast CancerNausea and VomitingStage I Breast Cancer+2 more
University of Washington 41
Not applicableActive Not RecruitingNCT03607552
What this trial is testing

Non-contrast DWI for Supplemental Screening

Who this might be right for
Breast Cancer
University of Washington 269
Very early researchStudy completedNCT00722059
What this trial is testing

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

Who this might be right for
Breast NeoplasmsBreast Abnormalities
University of Michigan 50
Large-scale testing (Phase 3)UnknownNCT03876886
What this trial is testing

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 200
Not applicableStudy completedNCT01424956
What this trial is testing

CRRS-4 Pivotal Somo•v™ ABUS ROC Reader Observer Study

Who this might be right for
Breast Cancer
U-Systems, Inc. 17
Not applicableUnknownNCT02209389
What this trial is testing

OctavaPink for Women With Dense Breast After Negative Mammography

Who this might be right for
Breast Cancer
Eventus Diagnostics Ltd 1,750
Load More Results